Procalcitonin serum concentration in lung transplant recipients during mold colonization or infection

S Zegleń1, M Sioła, E Woźniak-Grygiel

  • 1Departament and Clinic of Cardiac Surgery and Transplantology, Silesian Centre for Heart Diseases, Zabrze, Poland. slawekzeglen@poczta.onet.pl

Abstract

Insights

Mold colonization is common in lung transplant recipients. Procalcitonin (PCT) levels may help diagnose mold infections, even with prophylaxis.

Area of Science:

  • Medical Mycology
  • Transplant Surgery
  • Infectious Diseases

Background:

  • Lung transplant recipients face a high risk of mold colonization and infection.
  • Evaluating the frequency of mold presence and serum procalcitonin (PCT) concentrations is crucial in this patient population.

Purpose of the Study:

  • To determine the incidence of mold colonization and infection in lung transplant recipients.
  • To assess the utility of procalcitonin (PCT) serum concentrations as a diagnostic marker for mold infections.

Main Methods:

  • A cohort of 49 lung transplant recipients was studied.
  • Molds were identified using standard microbiological techniques.
  • Procalcitonin (PCT) levels were measured via immunoluminescence assay, with defined ranges for infection risk.

Main Results:

  • Mold presence in lower respiratory tract samples was observed in 49% of patients.
  • Aspergillus, Penicillium, and Zygomycetes were the most common molds identified.
  • The average PCT level was 0.5±0.7 ng/mL, with varying PCT ranges correlating to infection risk categories.

Conclusions:

  • Mold colonization is a frequent complication following lung transplantation, necessitating vigilance despite prophylaxis.
  • Procalcitonin shows potential as a valuable biomarker for diagnosing mold infections in lung transplant patients.